Less Ads, More Data, More Tools Register for FREE

Monday broker round-up

Mon, 08th Oct 2018 13:07
(Sharecast News) - Mediclinic International: Investec upgrades to buy with a target price of 448p.Pearson: Berenberg reiterates sell with a target price of 550p.Astrazeneca: Deutsche Bank reiterates buy with a target price of 6,400p.Glaxosmithkline: Deutsche Bank reiterates hold with a target price of 1,525p.MONDI: Deutsche Bank reiterates buy with a target price of 2,600p.WPP Group: Deutsche Bank reiterates hold with a target price of 1,430p.Tullow Oil: Morgan Stanley reiterates overweight with a target price of 355p.Brooks Macdonald: Numis downgrades to add with a target price of 2,210p.UNITE Group: Numis reiterates hold with a target price of 900p.Reach: Numis reiterates buy with a target price of 208p.Rathbones: Numis upgrades to add with a target price of 2,730p.Centamin: Numis reiterates buy with a target price of 130p.Mitie: Canaccord reiterates buy with a target price of 300p.Ferguson: Berenberg reiterates buy with a target price of 7,000p.Johnson Matthey: Morgan Stanley reiterates overweight with a target price of 3,900p. Tullow Oil Astrazeneca Pearson Relx Brooks Macdonald Johnson Matthey Mitie Rathbone Ferguson Glaxosmithkline WPP Unite Mondi Reach Plc

Shares in this article

Related News

LONDON BROKER RATINGS: Citi and Jefferies say buy Astra after tumble
54 mins ago

LONDON BROKER RATINGS: Citi and Jefferies say buy Astra after tumble

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:

Tech rebound lifts European shares after three-day slide
16 hours ago

Tech rebound lifts European shares after three-day slide

* Tech stocks gain, healthcare lags

Market News Soitec + 5 more shares
LONDON MARKET CLOSE: FTSE 100 held back by AstraZeneca trial setback
17 hours ago

LONDON MARKET CLOSE: FTSE 100 held back by AstraZeneca trial setback

(Alliance News) - Heavy falls in AstraZeneca saw London's FTSE 100 underperform European peers, while investors continue to weigh developments in the ...

Market News Astrazeneca + 12 more shares